This year, the American Academy of Allergy, Asthma and Immunology (AAAAI) has accepted four abstracts authored by Propeller Health and its research partners.
Our latest findings on asthma care, including how simplified dose frequency may increase medication adherence and how digital health can support improved pediatric asthma outcomes, will be presented at the AAAAI Annual Meeting on February 25-28. Read brief summaries of each abstract below or click the links to view them online.
Differences in medication adherence by dosing schedule among patients with asthma
Presented by Propeller and our research partner, Children’s Hospital Colorado
Summary: Patients with asthma may be prescribed once- or twice-daily dosing of controller inhalers. Researchers assessed differences in objectively-recorded medication adherence by dosing schedule and age. Among the study group, those who were prescribed once-daily dosing schedules were significantly more likely to adhere to their controller medications compared to those with twice-daily schedules. This finding held true even when controlling for age.
Feasibility of capturing self-reported asthma exacerbations with a digital self-management platform
Presented by Propeller
Summary: A primary goal of asthma care is reducing exacerbation risk. Propeller found that monthly self-report surveys conducted through its digital health app for chronic respiratory disease may be a feasible way to capture information about acute care events, including emergency department visits and hospitalizations. Combining insights from inhaler use trends and self-reported exacerbations may support early prediction of symptom worsening in patients with asthma.
Changes in remote care adoption for asthma during the COVID-19 pandemic
Presented by Propeller
Summary: The COVID-19 pandemic led to greater adoption of virtual and remote care. Propeller sought to understand which remote care tools and monitoring devices patients with asthma used and whether they perceived value in their virtual care. Survey results indicate patients used a myriad of remote tools for their asthma management during the COVID-19 pandemic, such as televisit platforms and online prescription services, and that the majority were generally satisfied with remote care.
Impact of electronic medication monitoring on pediatric asthma severity and control in a real-world multidisciplinary clinic
Presented by our research partner, Children’s Hospital Colorado
Summary: Compared to adult asthma, the impact of electronic medication monitoring (EMM) on pediatric asthma outcomes has not been well described in research. This study assessed changes in asthma severity, control, and rescue inhaler use after 6 months of EMM use in real-world, poorly controlled pediatric asthma patients. Researchers found that the use of an EMM in pediatric patients – as part of a multidisciplinary care plan – was associated with improved asthma control and decreased rescue inhaler use.